SCHEMBL4451549

SCHEMBL4451549

CSc1nc(CCCO)cc(-c2ccc(C)c(C)c2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.44
THRB P10828 2/20 0.40
KMT2A Q03164 1/20 0.40
KCNH2 Q12809 1/20 0.36
MAPT P10636 4/20 0.36
TLR8 Q9NR97 3/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 3/20 0.34
ALDH1A1 P00352 4/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PLA2G7 Q13093 1/20 0.33
ALPL P05186 1/20 0.33
CA9 Q16790 1/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
LMNA P02545 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4442745 0.77 CTSK (0.74) CTSKKCNH2CTSS
SCHEMBL4448000 0.77 CTSK (0.51) CTSKKCNH2TLR8CYP1A2CYP2C9
SCHEMBL4444259 0.76 CTSK (0.42) CTSKKMT2AKCNH2TP53ALDH1A1
SCHEMBL4453870 0.76 CTSK (0.65) CTSKKCNH2TLR8CYP1A2CYP2C9
SCHEMBL4442120 0.75 CTSK (0.42) CTSKKCNH2TLR8CTSSPTGDR
SCHEMBL23360982 0.74 MAPT (0.40) CTSKTHRBKMT2AMAPTNPC1
SCHEMBL4442123 0.70 TLR8 (0.34) CTSKTHRBKMT2AKCNH2TLR8
SCHEMBL5751623 0.69 HTR1B (0.41) CTSKTHRBKCNH2MAPTTLR8
SCHEMBL5796401 0.69 CTSK (0.43) CTSKTHRBKMT2AKCNH2TLR8
SCHEMBL5592998 0.64 MAPT (0.52) THRBKMT2AMAPTNPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589095-B2 4-phenyl-pyrimidine-2-carbonitrile derivatives N.V. ORGANON (NL) 2009-09-15 US disclosed
EP-1758870-B1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES ORGANON NV (NL) 2008-08-13 EP disclosed
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives Cai, Jiaqiang 2008-04-17 US disclosed
EP-1758870-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. Organon (NL) 2007-03-07 EP disclosed
WO-2005121106-A1 4-PHENYL-PYRIMIDINE-2-CARBONITRILE DERIVATIVES N.V. ORGANON (NL) 2005-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090813-A1 4-Phenyl-Pyrimidine-2-Carbonitrile Derivatives P2RY4, P2RX4, P2RY1 CTSK 1852/4885THRB 3078/4885KMT2A 3689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.